Related Experiment Video
Updated: Jul 16, 2026
12:43
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
Dendritic cell-based vaccine against coccidioides infection
1Department of Pharmaceutical Sciences, 1110 North Stonewall Avenue, Oklahoma City, OK 73117, USA. Shanjana-Awasthi@ouhsc.edu
Annals of the New York Academy of Sciences
|March 17, 2007
Summary
A dendritic cell (DC) vaccine shows promise for treating Coccidioides infections. This study found DCs act as powerful adjuvants, activating protective immune responses in mice against Coccidioides posadasii.
Area of Science:
- Immunology
- Infectious Diseases
- Vaccinology
Background:
- Coccidioides fungal infections cause coccidioidomycosis, prevalent in the southwestern US, with varied severity.
- Urgent need exists for effective Coccidioides therapy or vaccines due to endemicity, relapse, and virulence.
- T cell response differences influence susceptibility to Coccidioides infection in humans and murine models.
Purpose of the Study:
- To investigate the immunostimulatory potential of a dendritic cell (DC)-based vaccine against Coccidioides posadasii.
- To evaluate the efficacy of DCs as an adjuvant in a murine model.
Main Methods:
- A DC-based vaccine was developed and tested in a murine model.
- Immune responses were analyzed to assess protective effects against C. posadasii.
Main Results:
- Dendritic cells demonstrated potent adjuvant capabilities.
- The DC-based vaccine activated protective immune responses in mice challenged with C. posadasii.
Conclusions:
- DC-based vaccines hold potential as a novel therapeutic strategy against coccidioidomycosis.
- DCs can effectively stimulate protective immunity against Coccidioides fungal infections.
Related Concept Videos
01:51Vaccinations
Overview
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...